Reauthorizes the Stem Cell Therapeutic and Research Act of 2005 through 2031.
The Stem Cell Therapeutic and Research Reauthorization Act of 2026 extends the Stem Cell Therapeutic and Research Act of 2005 through 2031. It reauthorizes funding for the C.W. Bill Young Cell Transplantation Program and amends the Cord Blood Inventory. The bill ensures continued support for stem cell research and therapies, aiming to advance medical treatments and improve patient outcomes.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.